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Nail-Patella syndrome is an autosomal dominant multisystem 
disorder primarily affecting skeletal and connective tissues. 
Primary features of the syndrome include dysplasia of the nails, 
knees, and elbows. Nails are typically hypoplastic, absent, or 
dystrophic. Patellae are often small or irregularly shaped. Elbow 
abnormalities include dysplasia of the radial head and hypopla-
sia of the lateral epicondyle and capitellum. Joints may swell, 
dislocate, display hypermobility, or display early degenerative 
arthritis. Iliac horns are observed radiologically in approxi-
mately 70% of cases. Other features include renal dysfunction 
and, less frequently, glaucoma. Renal dysfunction is observed 
in approximately 40% of cases, with end-stage renal diseases 
occurring in approximately 5% of cases. Glaucoma is observed 
more frequently and at a younger age in this population. The 
overall presentation can vary widely from one affected indi-
vidual to another, with various manifestations ranging from 
severe to totally absent on a case-by-case basis. Nail changes 
are the most constant feature of Nail-Patella syndrome and are 
observed in approximately 98% of cases. The incidence of Nail-
Patella syndrome is thought to be 1 in 50,000.1,2
Loss-of-function mutations in LMX1B are the only known 
genetic cause of Nail-Patella syndrome. LMX1B is a WNT sig-
naling-responsive transcription factor crucial for mesenchymal 
dorsoventral patterning in developing limbs.3 WNT signaling 
plays a major role in a wide variety of embryonic develop-
ment processes, and it is thought that the timing and restricted 
expression of LMX1B, as well as other cooperating and com-
pensating signaling pathways, underlie both the constraints 
on abnormalities typically observed in Nail-Patella syndrome 
and the heterogeneity of clinical presentation observed from 
patient to patient.4 LMX1B mutations account for 95% of all 
Nail-Patella syndrome cases,2 leaving some cases unexplained 
even after comprehensive LMX1B mutation profiling.
Here, we present the exome sequencing findings for four 
generations of a family with nail dysplasia and some features 
of Nail-Patella syndrome. Prior to referral for exome sequenc-
ing, the proband of this family underwent workup for Nail-
Patella syndrome; however, her pelvic radiograph results were 
negative for iliac horns, her patellas were not small, and test 
results were negative for LMX1B mutation. Although many 
of the classic findings for Nail-Patella syndrome were not 
observed, given the similarity of the nail dysplasia observed 
in this family to that observed in Nail-Patella syndrome and 
the co-occurrence of joint laxity, the case was referred for 
exome sequencing for a suspected Nail-Patella-like disorder 
or other connective-tissue disorder. Exome sequencing, bio-
informatic analysis, and application of standard inheritance-
based, population-based, and coding impact filters resulted 
in the conclusion that a loss-of-function mutation in WIF1, 
a WNT signaling regulator involved in mesoderm segmenta-
tion,5 was the suspected novel cause of the Nail-Patella-like 
disorder observed in this family.
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Purpose: Nail-Patella syndrome is a dominantly inherited genetic 
disorder characterized by abnormalities of the nails, knees, elbows, 
and pelvis. Nail abnormalities are the most constant feature of Nail-
Patella syndrome. Pathogenic mutations in a single gene, LMX1B, 
a mesenchymal determinant of dorsal-ventral patterning, explain 
approximately 95% of Nail-Patella syndrome cases. However, 5% of 
cases remain unexplained.
Methods: Here, we present exome sequencing and analysis of four 
generations of a family with a dominantly inherited Nail-Patella-like 
disorder (nail dysplasia with some features of Nail-Patella syndrome) 
who tested negative for LMX1B mutation.
Results: We identify a loss-of-function mutation in WIF1 
(NM_007191 p.W15*), which is involved in mesoderm segmenta-
tion, as the suspected cause of the Nail-Patella-like disorder observed 
in this family.
Conclusions: Mutation of WIF1 is a potential novel cause of a Nail-
Patella-like disorder. Testing of additional patients negative for 
LMX1B mutation is needed to confirm this finding and further clar-
ify the phenotype.
Genet Med advance online publication 6 April 2017
Key Words: Fong disease; HOOD syndrome; nail dysplasia; 
Nail-Patella syndrome; Turner-Kieser syndrome
1Department of Pediatrics, University of California, San Diego, and Rady Children’s Hospital, San Diego, California, USA; 2The Scripps Translational Science Institute, La Jolla, 
California, USA; 3Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA. Correspondence: Ali Torkamani 
(atorkama@scripps.edu)
Mutation of WIF1: a potential novel cause of a  
Nail-Patella-like disorder
Marilyn C. Jones, MD1, Sarah E. Topol, RN2, Manuel Rueda, PhD2, Glenn Oliveira, BS2, 
Tierney Phillips, BA2, Emily G. Spencer, PhD2 and Ali Torkamani, PhD2,3
Open
Genetics in meDicine  |  Volume 19  |  Number   |   201710 October 1179
JONES et al  |  WIF1 and Nail-Patella-like disorderBrief report
MATERIALS AND METHODS
Study consent
Study participants provided written informed consent and the 
protocol was approved by the institutional review board of 
Scripps.
Whole-exome sequencing, variant calling, and filtration
DNA was extracted from freshly drawn blood and whole-
exome sequencing (WES) was pursued utilizing Agilent 
SureSelect exome hybridization followed by barcoding and 
sequencing of paired 100-bp reads on an Illumina HiSeq2500 
instrument. Read mapping, variant calling, and quality filtra-
tion were performed using a BWA-GATK best-practices vari-
ant quality score recalibration approach. Mean coverage of 86× 
per individual was achieved with 98.1% of the target exome 
covered by >10 reads. Variant annotation was performed using 
the SG-ADVISER system.4 A series of filters was applied to 
derive a set of candidate disease-causative variants (Table 2): (i) 
population-based filtration, because of the rarity of this condi-
tion, removed variants present at >0.2% allele frequency in the 
Exome Aggregation Consortium,6 1000 Genomes,7 the NHLBI 
Exome Sequencing Project,8 or Scripps Wellderly populations;9 
(ii) functional impact-based filtration to remove variants that 
are not nonsynonymous, frameshift, in-frame, nonsense, or do 
not affect canonical splice-site donor/acceptor sites; and (iii) 
inheritance-based filters to remove variants that do not segre-
gate in the family in a manner consistent with autosomal domi-
nant inheritance.
RESULTS
Phenotype
The proband was a 45-year-old woman presenting with dysplas-
tic ridged nails, and joint laxity. She had a history of multiple 
fractures with minimal trauma; a torn anterior cruciate liga-
ment; subluxations of the left shoulder, knee, and temporoman-
dibular joints; spondylolisthesis; and arthritis. Prior to referral 
for exome sequencing, she was evaluated for Nail-Patella syn-
drome with radiographs of the knees and pelvis, which docu-
mented patellas of normal size and no iliac horns. Genetic 
testing for pathogenic deletions, duplications, and mutations in 
LMX1B was negative (Fulgent Diagnostics).
Nail dysplasia and joint laxity co-occur in a variety of disor-
ders, all of which are associated with additional severe findings. 
A search for disorders with combined nail dysplasia (human 
phenotype ontology identifier HP:0002164) and joint lax-
ity (HP:0001388) via the Phenomizer tool10 returned possible 
diagnoses that were severe syndromic disorders (Meier-Gorlin 
syndrome, Costello syndrome, chromosome 2q32-q33 deletion 
syndrome, Weaver syndrome, Coffin-Lowry syndrome, cranio-
frontonasal syndrome, and focal dermal hypoplasia), severe bone 
development disorders (metaphyseal chondrodysplasia and cra-
nioectodermal dysplasia), or Nail-Patella syndrome. Therefore, 
although many of the classic findings for Nail-Patella syndrome 
were not observed, we concluded that the phenotype observed in 
the proband was nail dysplasia with some features of Nail-Patella 
syndrome, or what we refer to as a Nail-Patella-like disorder.
Family history included four generations of 14 total individu-
als with nail dysplasia and a variety of connective-tissue con-
cerns (Table 1, Figure 1, Supplementary Figures S2 and S3 
online). All affected family members belonged to the maternal 
lineage of the proband, including the mother, grandmother, 
and maternal aunts, uncles, cousins, brother, and niece of the 
proband (see pedigree in Figure 2); there were two instances 
of male-to-male transmission supporting autosomal domi-
nant inheritance in the maternal lineage. To identify candi-
date genetic variants underlying the Nail-Patella-like disorder 
observed in four generations of this family, WES was pursued 
for five individuals in the family, the mother-father-proband 
trio and two cousins (the most distantly related family members 
available for sequencing). Follow-up genotyping of candidate 
variants was performed in these individuals plus an additional 
five members of the family.
Table 1 Phenotype description
Subject Age Nail dysplasia Iliac horns Joint problems Renal disease Glaucoma Other
ID41P (proband) 45 Present Absent Lax joints, multiple subluxation, torn 
ACL, multiple fractures, arthritis
Irritable bowel 
syndrome
ID41M (mother) 73 Present Unknown Patellar tendon rupture, 3 knee 
replacements, scoliosis
Chronic kidney 
disease
Present Breast cancer, 
chronic cough
ID41K4 (cousin) 48 Present Unknown
ID41K5 (cousin) NA Present Unknown Crohn’s disease
ID41K6 (daughter) 15 Present Absent Hip dysplasia, torn ulnar collateral 
ligament, chronic back pain
ID41K7 (daughter) 13 Present Unknown Recurrent ankle sprain,  
microinstability at fibular fracture
ID41K8 (son) 13 Present Unknown Torn ankle tendon Cranial nerve 
palsy
ID41K9 (uncle) NA Present Unknown Chronic cough
ID41K10 (aunt) NA Present Unknown Multiple joint symptoms,  
hip replacement
Chronic cough
Grandmother 78 Present Unknown Arthritis Renal failure Present
All familial relations are maternal in respect to the proband.
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Sequencing and candidate variant identification
WES (~86× coverage, 98.1% of target exome covered by 10+ 
reads) was performed for the affected proband (ID41P), 
unaffected father (ID41F), affected mother (ID41M), and two 
affected maternal cousins (ID41K4 and ID41K5) (see Materials 
and Methods for details) (Figure 1b). Variants discovered by 
WES were annotated by SG-ADVISER.4 Nonsynonymous, in-
frame, frameshift, nonsense, and consensus splice site variants, 
at a threshold population allele frequency of <0.2%, were fil-
tered under an autosomal dominant model of inheritance. This 
allele frequency threshold is 100-fold higher than the incidence 
of Nail-Patella syndrome (1 in 50,000). Twelve candidate caus-
ative variants were retained after filtration (Table 2).
Follow-up genotyping, via Sanger sequencing, for the 12 can-
didate variants was performed in the above mentioned individ-
uals plus three affected children (ID41K6, ID41K7, ID41K8), 
an affected maternal uncle (ID41K9), and an affected mater-
nal aunt (ID41K10) of the proband (Figure 1b). This process 
ultimately resulted in the retention of three candidate variants: 
KRT74 p.R379L, RDH16 p.R153G, and WIF1 p.W15* (shown 
in boldface in Table 2).
DISCUSSION
Relaxed allele frequency-based filtration of coding variants 
inherited in an autosomal dominant fashion in the study family 
resulted in three candidate genes for the observed Nail-Patella-
like disorder: KRT74, RDH16, and WIF1. It should be noted 
that the underlying assumption leading to the identification of 
these three candidate variants was that the disorder is driven 
by a coding mutation captured by exome sequencing, and that 
the Nail-Patella-like disorder observed in this family is rare. No 
assumptions regarding the specific phenotype were included in 
this variant prioritization approach—i.e., variants underlying 
other known causes of nail dysplasia or other connective-tissue 
disorders would have been captured by our analysis approach. 
Given our initial assumptions, further filtration of the candidate 
variants by allele frequency under the assumption of complete 
penetrance, and prioritization based on biological relevance of 
the candidate genes, resulted in the conclusion that mutation 
of WIF1 was the suspected cause of Nail-Patella-like disorder 
in this family.
The candidate variant in KRT74 can probably be removed 
from consideration on the basis of phenotype as well as allele 
frequency. KRT74 is an epithelial keratin known to cause auto-
somal dominant woolly hair and autosomal recessive ecto-
dermal dysplasia.11 The family in this report had normal hair, 
teeth, skin, and sweat glands. Moreover, this particular variant 
in KRT74 (rs143748352) has been observed at 0.047% allele fre-
quency in Europeans,6 which is an approximately 25-fold excess 
of the incidence of Nail-Patella syndrome. Therefore, under the 
assumption of near-complete penetrance, which was appropri-
ate given the pattern of inheritance observed in this family, the 
variant in KRT74 was unlikely to be a cause of the observed 
Nail-Patella-like disorder. However, we could not fully exclude 
the possibility that the variant contributed to a portion of the 
phenotype observed in this family.
The candidate variant in RDH16 cannot definitively be elimi-
nated from consideration due to allele frequency, but its known 
Figure 1 Images of the proband and children’s nail dysplasia. (a) Both 
thumbs of the proband (ID41P). (b) Fifth toenail of the proband’s daughter 
(ID41K7). (c,d) Toenails and fingernails of the proband’s son (ID41K8). Note 
the variable ridging, dysplasia, and thin texture.
a b
c d
Figure 2 Family pedigree. Pedigree of four generations of a family with 
a dominantly inherited Nail-Patella-like disorder. The proband is indicated 
by the arrow. Identifiers are provided for family members that underwent 
genetic analysis. Corresponding identifiers can be found in the Tables. Not 
all unaffected family members are depicted. Unaffected family members 
not pictured include three unaffected children of the pictured brother of the 
proband, four unaffected children of ID41K10, and an unaffected brother 
of ID41K4.
Joint abnormality
Nail dysplasia
ID41M ID41F ID41K9 ID41K10
ID41K4ID41K5ID41P
ID41K6 ID41K7 ID41K8
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function does not appear to fit the observed phenotype. The 
variant in RDH16 (rs372580365) has been observed at 0.006% 
allele frequency in Europeans,6 which is slightly (3×) greater 
than the incidence of Nail-Patella syndrome—an excess that 
would be amplified further given that 95% of cases are already 
explained by mutation in LMX1B mutation (60× greater). 
Moreover, RDH16 is a liver-specific retinol dehydrogenase 
that plays no known role in connective-tissue biology. Finally, 
RDH16 knockout mice have no significant abnormalities.12
However, the variant in WIF1 is a strong candidate as the 
cause of a novel Nail-Patella-like disorder. The nonsense variant 
(WIF1 p.W15*) observed in this gene has not previously been 
observed in more than 100,000 genomes.6 Therefore, the fre-
quency of this variant is consistent with a fully penetrant cause 
of the observed disorder. Moreover, WIF1 is a secreted antago-
nist of WNT signaling, expressed predominantly at the super-
ficial layer of epiphyseal and articular cartilage, and it is known 
to promote chondrogenesis.13 In mouse models of arthritis, loss 
of WIF1 aggravates cartilage damage.14 The observed nonsense 
mutation in WIF1 is expected to result in the complete loss of 
the N-terminal signal peptide of WIF1 (amino acids 1–28) and 
thus inhibit its secretion into the extracellular matrix, where it 
inhibits WNT factors. Therefore, loss of WIF1 function would 
be expected to lead to joint cartilage abnormalities. Moreover, 
WIF1 functions within the same molecular signaling network 
as LMX1B—a WNT-responsive transcription factor.15
The WNT pathway controls a variety of embryonic develop-
ment processes. The specificity of WNT signaling is achieved 
through a variety of WNT ligands, each of which is subject to 
highly organized temporal and spatially restricted patterns of 
expression to coordinate embryonic development.16 A com-
plex, and not fully understood, interplay between WNT and 
other signaling cascades is known to mediate joint develop-
ment.17 Similarly, WNT signaling is known to play a central 
role in nail development,18 although the precise molecular 
mechanisms have not been well described. It is thought that the 
role of LMX1B as both a necessary and sufficient mediator of 
WNT signaling to specify dorsal limb patterning, specifically 
through induction by the WNT ligand WNT7A, underlies the 
primary abnormalities observed in Nail-Patella syndrome.15 
However, LMX1B is also involved in a variety of other com-
plex WNT-dependent processes, in which LMX1B function 
may be compensated for by other factors, potentially leading to 
the phenotypic heterogeneity observed across Nail-Patella syn-
drome cases.19 Similarly, WIF1 interacts with a variety of WNT 
ligands, including WNT7A, and thus participates in an overlap-
ping set of WNT signaling functions as LMX1B.20 However, the 
details of the role of WIF1 in embryonic and other develop-
mental processes have not been well described.
Further study of additional WIF1-positive cases would help 
elucidate the role of WIF1 mutation in Nail-Patella-like disorder 
and the role of WNT signaling in nail and joint development. 
The phenotype in this family evolves over time. The majority 
of affected individuals have abnormal nails at birth but do not 
manifest other features until they become competitively active 
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during adolescence. Multiple joint dislocations and arthritis 
are most troublesome. Two older members of the family have 
developed renal issues and one has glaucoma. It is unclear 
whether these features are related to the WIF1 mutation or are 
unrelated. Longitudinal follow-up of family members is clearly 
warranted. The complete phenotypic spectrum due to loss of 
WIF1 function may be clarified if more families are reported.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper 
at http://www.nature.com/gim
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